UA113771C2 - PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases

Info

Publication number
UA113771C2
UA113771C2 UAA201502305A UAA201502305A UA113771C2 UA 113771 C2 UA113771 C2 UA 113771C2 UA A201502305 A UAA201502305 A UA A201502305A UA A201502305 A UAA201502305 A UA A201502305A UA 113771 C2 UA113771 C2 UA 113771C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
allergic
treatment
skin diseases
inflammatory skin
Prior art date
Application number
UAA201502305A
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAA201502305A priority Critical patent/UA113771C2/en
Publication of UA113771C2 publication Critical patent/UA113771C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід належить до фармацевтичної композиції у формі дерматологічної мазі для лікування алергічних і запальних захворювань шкіри. Фармацевтична композиція як комплекс біологічно активних речовин містить сухий екстракт солодкового кореня, тербінафіну гідрохлорид і ефірну олію лаванди. Мазева основа дерматологічної мазі містить віск бджолиний, емульгатор № 1, олію соєву, ізопропілміристат, пропіленгліколь та воду очищену.The invention relates to a pharmaceutical composition in the form of a dermatological ointment for the treatment of allergic and inflammatory skin diseases. The pharmaceutical composition as a complex of biologically active substances contains a dry extract of licorice, terbinafine hydrochloride and lavender essential oil. The ointment base of the dermatological ointment contains beeswax, emulsifier No. 1, soybean oil, isopropyl myristate, propylene glycol and purified water.

UAA201502305A 2015-03-16 2015-03-16 PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases UA113771C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201502305A UA113771C2 (en) 2015-03-16 2015-03-16 PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201502305A UA113771C2 (en) 2015-03-16 2015-03-16 PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases

Publications (1)

Publication Number Publication Date
UA113771C2 true UA113771C2 (en) 2017-03-10

Family

ID=58504170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201502305A UA113771C2 (en) 2015-03-16 2015-03-16 PHARMACEUTICAL COMPOSITION IN THE FORM OF DERMATOLOGICAL Ointment for the Treatment of Allergic and Inflammatory Skin Diseases

Country Status (1)

Country Link
UA (1) UA113771C2 (en)

Similar Documents

Publication Publication Date Title
PH12018502634A1 (en) Topical compositions of apremilast
CL2018001089A1 (en) Valbenazine salts and polymorphs thereof.
MX2021001439A (en) Compositions and methods for the treatment of meibomian gland dysfunction.
BR112015021888A8 (en) dna-pk inhibitors, their uses and pharmaceutical composition
EA201591751A1 (en) TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS
BR112015016315A2 (en) fluoro- [1,3] oxazine as bace1 inhibitors
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
MX349594B (en) Composition for cosmetic use suitable to produce a pigmentation effect on hair.
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
BR112018067946A2 (en) topical formulations containing cyclosporine and their uses
EA201890449A1 (en) FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
SV2018005783A (en) 5,6,7,8-TETRAHIDRO [1,2,4] TRIAZOLO [4,3-A] PIRIDIN-3 (2H) -ONAS AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO [2,1 -C] [1,2,4] TRIAZOL-3-ONES REPLACED ITS USE
CO2017003321A2 (en) Lysine gingipain inhibitors
IN2014DN08440A (en)
CO2018008450A2 (en) Derivatives of 8-amino-2-oxo-1,3-diaza-spiro- [4.5] -decane
MX2018000262A (en) Therapeutic uses of berberine formulations.
MX2016016400A (en) Stabilized oxymetazoline formulations and their uses.
EA201500992A1 (en) LEDENET FOR TREATMENT OF THORN PAIN, CHOKING OF THE VOICE AND RELATED DRY Cough AND INFLAMMATORY DISEASES OF THE CAVITY AND THROAT
CL2008002060A1 (en) Compounds derived from sulfonamide, inhibitors of beta amyloid production; Preparation method; pharmaceutical composition; pharmaceutical kit; and use in the treatment of diseases such as Alzheimer's, amyloid angiopathy, down syndrome, among others.
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
MX2017016226A (en) Pharmaceutical compositions comprising polyalkylene glycol derivatives.
MA50458A (en) TOPICAL FORMULATIONS INTENDED FOR THE TREATMENT OF DERMATOLOGICAL AFFECTIONS INCLUDING HIPPOCRATIC BALVITY
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
CL2018002848A1 (en) Liquid phosphoplatin formulations